Table 1.
Baseline characteristics of the study population
| Characteristic | Population (N = 8446) |
|---|---|
| Age (years) | 48.6 ± 13.6 |
| Men, N (%) | 4253 (50) |
| Prevalent myocardial infarction, N (%) | 181 (2.1) |
| Cardiovascular risk factors | |
| Body mass index (kg/m2) | 26.7 ± 4.6 |
| Systolic blood pressure (mmHg) | 136 ± 20 |
| Antihypertensive treatment, N (%) | 1103 (13) |
| Total cholesterol (mmol/L) | 5.47 (2.13–13.6) |
| Current smoking, N (%) | 1944 (23) |
| Diabetes, N (%) | 493 (5.8) |
| Biomarker | |
| Creatinine (mg/dL) | 0.90 (0.10–14.9) |
| Glomerular filtration rate (mL/min/1.73 m2) | 89.5 (2.3–244) |
| BNP (pg/mL) | 14.4 (0.1–2106) |
| NT-proBNP (pg/mL) | 44.4 (5.0–9541) |
| MR-proANP (pmol/L) | 43.0 (4.6–1240) |
For categorical variables absolute and relative frequencies are given. Continuous variables are represented as mean ± standard deviation for near to normally distributed variables or median (range).
BNP, B-type natriuretic peptide; NT-proBNP, N-terminal pro B-type natriuretic peptide; MR-proANP, mid-regional pro atrial natriuretic peptide.